# DSA Intragraft in Lung Transplantation: Diagnostic and Prognostic Value in Antibody Mediated Rejection

> **NCT03702257** · NA · UNKNOWN · sponsor: **University Hospital, Strasbourg, France** · enrollment: 80 (estimated)

## Conditions studied

- Lung Transplant Recipient
- Donor Specific Antibodies
- Antibody Mediated Rejection

## Interventions

- **PROCEDURE:** bronchoscopy.

## Key facts

- **NCT ID:** NCT03702257
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-23
- **Primary completion:** 2026-02-22
- **Final completion:** 2026-02-22
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2022-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03702257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03702257, "DSA Intragraft in Lung Transplantation: Diagnostic and Prognostic Value in Antibody Mediated Rejection". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03702257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*